ACCOMPLISH

Serial Number 98104260
731

Registration Progress

Application Filed
Jul 27, 2023
Under Examination
Jul 2, 2024
Approved for Publication
May 7, 2024
Published for Opposition
May 7, 2024
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Jan 02, 2026 7 days

Trademark Image

ACCOMPLISH

Basic Information

Serial Number
98104260
Filing Date
July 27, 2023
Published for Opposition
May 7, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
731
Status Date
Apr 14, 2025
Application
Pending
Classes
042

Rights Holder

Cingulate Therapeutics LLC

16
Address
1901 W 47th Place, Suite 310
Kansas City, KS 66205

Ownership History

Cingulate Therapeutics LLC

Original Applicant
16
Kansas City, KS

Cingulate Therapeutics LLC

Owner at Publication
16
Kansas City, KS

Legal Representation

Attorney
Susan Neuberger Weller

USPTO Deadlines

Next Deadline
7 days remaining
NOA E-Mailed - SOU Required
Due Date
January 02, 2026
Extension Available
Until July 02, 2026

Application History

16 events
Date Code Type Description Documents
Apr 15, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 14, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Apr 14, 2025 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 14, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 7, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 7, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Aug 7, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 7, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 2, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 7, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 7, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 17, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 1, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 29, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 27, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 31, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
conducting clinical trials for others in the field of pharmaceuticals for the treatment of attention deficit hyperactivity disorder (ADHD)

Classification

International Classes
042